|
|
||||||||
Ann Thorac Surg 2005;80:1067-1072
© 2005 The Society of Thoracic Surgeons
a Department of Cardiovascular and Thoracic Surgery, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, Kerala, India
b Department of Anesthesiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, Kerala, India
Accepted for publication March 16, 2005.
* Address reprint requests to Dr Varma, B-8, New Faculty Quarters, Chitra Staff Quarters, Poonthi Road, Thiruvananthapuram, Kerala 695 011, India (Email: pkvarma{at}sctimst.ker.nic.in; varmapk{at}gmail.com).
BACKGROUND: This retrospective study was designed to study the clinical profile, indications, postoperative complications and long-term outcome of pulmonary aspergilloma operated in our institute.
METHODS: From 1985 to 2003, 60 patients underwent surgery for pulmonary aspergilloma at Sree Chitra Tirunal Institute for Medical Sciences and Technology.
RESULTS: The group consisted of 36 male patients and 24 female patients with a mean age of 42.7 ± 11.8 years. The most common indication for surgery was hemoptysis (93.3%). The common underlying lung diseases were tuberculosis (45%), bronchiectasis (28.3%), and lung abscess (11.6%). Fourteen patients (23%) had simple aspergilloma (SA) and 46 (77%) had complex aspergilloma (CA). The procedures performed were lobectomy (n = 55), pneumonectomy (n = 2), segmental resection (n = 2), and cavernoplasty (n = 2). One patient underwent bilateral lobectomy at 14 months interval. The operative mortality was 4.3% and 0% in CA and SA, respectively (p = 1.0). Major complications occurred in 26.1% patients of CA, whereas none occurred in SA (p = 0.052). The complications included bleeding (n = 2), prolonged air leak (n = 4), empyema (n = 4), repeated pneumothorax (n = 1), and wound dehiscence (n = 1). Three patients needed thoracoplasty. The mean follow-up period was 40 ± 24 months. The actuarial survival at 10 years was 78% and 92% for CA and SA, respectively. There was no recurrence of disease or hemoptysis.
CONCLUSIONS: Surgical resection of pulmonary aspergilloma prevents recurrence of hemoptysis. Complex aspergilloma resection was associated with low mortality but significant morbidity, whereas SA had no associated early mortality and morbidity. Long-term outcome is good for SA and satisfactory for CA.
This article has been cited by other articles:
![]() |
A. Brik, A. M. Salem, A. R. Kamal, M. Abdel-Sadek, M. Essa, M. El Sharawy, A. Deebes, and K. A. Bary Surgical outcome of pulmonary aspergilloma Eur. J. Cardiothorac. Surg., October 1, 2008; 34(4): 882 - 885. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Gadkowski and J. E. Stout Cavitary Pulmonary Disease Clin. Microbiol. Rev., April 1, 2008; 21(2): 305 - 333. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Memtsoudis, M. C. Besculides, L. Zellos, N. Patil, and S. O. Rogers Trends in lung surgery: United States 1988 to 2002. Chest, November 1, 2006; 130(5): 1462 - 1470. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |